Glucose control and medication adherence among veterans with diabetes and serious mental illness: Does collocation of primary care and mental health care matter?

Diabetes Care

Volumn 37, Issue 8, 2014, Pages 2261-2267

  Long, Judith A ^a,b   Wang, Andrew ^a   Medvedeva, Elina L ^a   Eisen, Susan V ^a,c   Gordon, Adam J ^a,d   Kreyenbuhl, Julie ^a,e   Marcus, Steven C ^a,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES CONTROL; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MEDICATION COMPLIANCE; MEDICATION POSSESSION RATIO; MENTAL DISEASE; MENTAL HEALTH CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIMARY HEALTH CARE; SELF REPORT; VETERAN; AGED; BLOOD; COHORT ANALYSIS; COMPLICATION; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; GOVERNMENT; MENTAL DISORDERS; MENTAL HEALTH SERVICE; METABOLISM; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; PRIMARY HEALTH CARE; SEVERITY OF ILLNESS INDEX; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 84904988778     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0051     Document Type: Article

References (31)

1. Cohen D, Stolk RP, Grobbee D.E., Gispen-de Wied CC. Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders. Diabetes Care 2006; 29: 786-791
2. Dixon L, Weiden P, Delahanty J., et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000; 26: 903-912
3. Menninger WC. The inter-relationship of mental disorder and diabetes mellitus. J Ment Sci 1935; 81: 332-357
4. Leslie DL, Rosenheck RA Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry 2004; 161: 1709-1711
5. Parks J, Svendsen D, Singer P., Foti ME. Report: morbidity and mortality in people with serious mental illness [Internet], 2006. Alexandria, VA, National Association of State Mental Health Program Directors Medical Directors Council. Available from http://www.nasmhpd.org/docs/publications/MDCdocs/ Mortality%20and%20Morbidity%20Final%20Report%208.18.08.pdf. Accessed 21 April 2014
6. Morden NE, Lai Z, Goodrich D.E., et al. Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia. Gen Hosp Psychiatry 2012; 34: 368-379
7. Miller DR, Safford MM, Pogach LM Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004; 27(Suppl. 2): B10-B21
8. Unützer J., Schoenbaum M, Druss B.G., Katon WJ. Transforming mental health care at the interface with general medicine: report for the presidents commission. Psychiatr Serv 2006; 57: 37-47
9. Druss BG, von Esenwein SA. Improving general medical care for persons with mental and addictive disorders: systematic review. Gen Hosp Psychiatry 2006; 28: 145-153
10. Druss BG, Rohrbaugh RM, Levinson C.M., Rosenheck RA. Integrated medical care for patients with serious psychiatric illness: a randomized trial. Arch Gen Psychiatry 2001; 58: 861-868
11. United States Department of Veterans Health. Mental Health Integration Home [Internet]. Available from http://www.va.gov/PrimaryCare/mhi/index.asp. Accessed 7 January 2013
12. Kilbourne AM, Lai Z, Bowersox N., Pirraglia P, Bauer MS. Does colocated care improve access to cardiometabolic screening for patients with serious mental illness? Gen Hosp Psychiatry 2011; 33: 634-636
13. Kilbourne AM, Pirraglia PA, Lai Z, et al. Quality of general medical care among patients with serious mental illness: does colocation of services matter? Psychiatr Serv 2011; 62: 922-928
14. Pirraglia PA, Kilbourne AM, Lai Z, Friedmann PD, O'Toole TP. Colocated general medical care and preventable hospital admissions for veterans with serious mental illness. Psychiatr Serv 2011; 62: 554-557
15. Blow FC, Zeber JE, McCarthy J.F., Valenstein M., Gillon L, Bingham CR. Ethnicity and diagnostic patterns in veterans with psychoses. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 841-851
16. Palmer BW, Dunn LB, Appelbaum P.S., et al. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry 2005; 62: 726-733
17. Steiner JF, Koepsell TD, Fihn S.D., Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 1988; 26: 814-823
18. Krapek K, King K, Warren S.S., et al Medication adherence and associated hemoglobin A1c in Type 2 diabetes. Ann Pharmacother 2004; 38: 1357-1362
19. DiMatteo MR. Variations in patients' adherencetomedical recommendations: aquantitative review of 50yearsofresearch. Med Care 2004; 42: 200-209
20. Kleinman NL, Schaneman JL, Lynch WD The association of insulin medication possession ratio, use of insulin glargine, and health benefit costs in employees and spouses with type 2 diabetes. J Occup Environ Med 2008; 50: 1386-1393
21. Chaudhry S, Jin L, Meltzer D. Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care 2005; 43: 607-615
22. Gold JM, Queern C, Iannone V.N., Buchanan RW. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. Am J Psychiatry 1999; 156: 1944-1950
23. Hobart MP, Goldberg R, Bartko J.J., Gold JM. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons. Am J Psychiatry 1999; 156: 1951-1957
24. Eisen SV, Normand S-L, Belanger AJ, Spiro A 3rd, Esch D. The revised behavior and symptom identification scale (BASIS-R): reliability and validity. Med Care 2004; 42: 1230-1241
25. VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus in Primary Care [Internet], 2013. Available from http://www. healthquality.va.gov/guidelines/CD/diabetes/AboutDM.asp. Accessed 7 January 2013
26. Jackson GL, Edelman D, Weinberger M. Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients. J Gen Intern Med 2006; 21: 1050-1056
27. Brown CH, Medoff D, Dickerson F.B., et al. Long-term glucose control among type 2 diabetes patients with and without serious mental illness. J Nerv Ment Dis 2011; 199: 899-902
28. Kreyenbuhl J, Dixon LB, McCarthy J.F., Soliman S., Ignacio RV, Valenstein M. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia? Schizophr Bull 2010; 36: 428-435
29. Kreyenbuhl J, Leith J, Medoff D.R., et al. A comparison of adherenceto hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness. Psychiatry Res 2011; 188: 109-114
30. Gerstein HC, Miller ME, Byington R.P., et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559
31. Krein SL, Bingham CR, McCarthy J.F., Mitchinson A., Payes J, Valenstein M. Diabetes treatment among VA patients with comorbid serious mental illness. Psychiatr Serv 2006; 57: 1016-1021